Table 2.
Patient Number | Age, y | Sex | End Point | Interval (d) | CCTA | 18F‐NaF PET/CT | ||
---|---|---|---|---|---|---|---|---|
Obstructive Stenosis | HRP | ≥1.28 TBRmax | Corresponding to M‐TBRmax | |||||
1 | 65 | Male | MI | 450 | Yes | No | No | No |
2 | 59 | Female | UA | 138 | No | No | Yes | Yes |
3 | 66 | Male | UA | 85 | No | Yes | Yes | No |
4 | 72 | Male | UA | 32 | Yes | No | Yes | Yes |
5 | 62 | Male | CR | 128 | Yes | No | No | No |
6 | 80 | Male | CR | 711 | No | Yes | Yes | Yes |
7 | 73 | Male | CR | 143 | Yes | Yes | Yes | No |
8 | 70 | Male | CR | 334 | Yes | Yes | Yes | Yes |
9 | 78 | Male | CR | 103 | Yes | No | No | No |
10 | 68 | Male | CR | 98 | Yes | Yes | Yes | Yes |
11 | 63 | Male | CR | 308 | No | Yes | Yes | Yes |
18F‐NaF indicates 18F‐sodium fluoride; CCTA, coronary computed tomography angiography; CR, coronary revascularization; CT, computed tomography; HRP, high‐risk plaque; MI, myocardial infarction; M‐TBRmax, maximum TBRmax per patient; PET, positron emission tomography; TBRmax, maximum tissue:background ratio; UA, unstable angina.